NASTRUZZI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 22.303
AS - Asia 10.845
EU - Europa 5.171
SA - Sud America 1.828
Continente sconosciuto - Info sul continente non disponibili 335
AF - Africa 235
OC - Oceania 16
AN - Antartide 1
Totale 40.734
Nazione #
US - Stati Uniti d'America 21.831
SG - Singapore 4.112
CN - Cina 2.764
BR - Brasile 1.417
UA - Ucraina 1.141
VN - Vietnam 1.087
HK - Hong Kong 893
IT - Italia 884
DE - Germania 855
TR - Turchia 670
GB - Regno Unito 560
FI - Finlandia 359
FR - Francia 316
SE - Svezia 307
RU - Federazione Russa 284
JP - Giappone 272
IN - India 223
BD - Bangladesh 201
CA - Canada 191
MX - Messico 171
AR - Argentina 134
PL - Polonia 132
ID - Indonesia 102
IR - Iran 94
ZA - Sudafrica 85
IQ - Iraq 76
CO - Colombia 75
NL - Olanda 75
EC - Ecuador 72
PK - Pakistan 55
VE - Venezuela 45
ES - Italia 40
AT - Austria 36
CL - Cile 33
PH - Filippine 32
UZ - Uzbekistan 31
MY - Malesia 30
TN - Tunisia 30
MA - Marocco 28
KR - Corea 26
SA - Arabia Saudita 26
LT - Lituania 24
BE - Belgio 23
EG - Egitto 23
JM - Giamaica 23
AE - Emirati Arabi Uniti 20
CH - Svizzera 20
PY - Paraguay 19
JO - Giordania 18
PT - Portogallo 18
PE - Perù 17
DO - Repubblica Dominicana 16
KE - Kenya 16
DZ - Algeria 15
ET - Etiopia 15
TW - Taiwan 15
NP - Nepal 14
AU - Australia 13
CR - Costa Rica 13
CZ - Repubblica Ceca 13
GT - Guatemala 12
KZ - Kazakistan 12
OM - Oman 9
PA - Panama 9
RO - Romania 9
IE - Irlanda 8
IL - Israele 8
AZ - Azerbaigian 7
BY - Bielorussia 7
DK - Danimarca 7
HN - Honduras 7
NI - Nicaragua 7
UY - Uruguay 7
AL - Albania 6
BO - Bolivia 6
GR - Grecia 6
HR - Croazia 6
HU - Ungheria 6
KW - Kuwait 6
LV - Lettonia 6
MD - Moldavia 6
NG - Nigeria 6
TT - Trinidad e Tobago 6
KH - Cambogia 5
LB - Libano 5
TH - Thailandia 5
BB - Barbados 4
MK - Macedonia 4
PS - Palestinian Territory 4
AO - Angola 3
BG - Bulgaria 3
BS - Bahamas 3
CI - Costa d'Avorio 3
EU - Europa 3
KG - Kirghizistan 3
MN - Mongolia 3
PR - Porto Rico 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
Totale 40.358
Città #
Singapore 2.520
Ashburn 2.178
Fairfield 2.044
Woodbridge 1.999
Houston 1.401
San Jose 1.362
Jacksonville 1.274
Ann Arbor 1.011
Santa Clara 953
Chandler 917
Hong Kong 877
Beijing 828
Seattle 818
Wilmington 767
Cambridge 651
Council Bluffs 544
Izmir 401
Ho Chi Minh City 364
Nanjing 349
New York 323
Dallas 313
Tokyo 261
Princeton 259
Hanoi 251
Los Angeles 248
Lauterbourg 225
Ferrara 192
Boardman 186
San Diego 171
Milan 143
São Paulo 134
Warsaw 123
Nanchang 110
Munich 109
Mexico City 106
Shenyang 100
Addison 91
Helsinki 87
Hebei 86
Tianjin 83
Shanghai 79
Changsha 77
Dearborn 73
Chicago 70
London 67
Hefei 65
Orem 65
Buffalo 58
Jiaxing 58
San Francisco 52
Da Nang 51
Moscow 51
Chennai 50
Rome 50
Rio de Janeiro 49
Toronto 49
Atlanta 48
Haiphong 48
Montreal 47
Redwood City 47
Brooklyn 46
Jakarta 46
Hangzhou 45
Mountain View 45
Jinan 44
Johannesburg 44
San Mateo 38
Bologna 37
Norwalk 36
Zhengzhou 36
Denver 35
Phoenix 35
Washington 34
Boston 33
Baghdad 32
Frankfurt am Main 32
Orange 32
The Dalles 32
Turku 31
Curitiba 29
Kunming 29
Tashkent 29
Falkenstein 28
Hải Dương 28
Mumbai 28
Guangzhou 27
Ningbo 27
Vienna 27
Bogotá 26
Stockholm 26
Auburn Hills 25
Brasília 25
Belo Horizonte 24
Bremen 23
Guayaquil 23
Brussels 22
Philadelphia 22
Amsterdam 21
Columbus 21
Poplar 21
Totale 27.257
Nome #
Biodistribution of nanostructured lipid carriers: a tomographic study 341
Liposome production by microfluidics: Potential and limiting factors 300
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study 299
Design production and characterization of drug delivery systems by Lab-on-a-Chip technology 296
Progesterone lipid nanoparticles: Scaling up and in vivo human study 283
Dedifferentiated Chondrocytes in Composite Microfibers As Tool for Cartilage Repair 269
A dielectrophoretic microchip for controlled cell targeting with functionalized microspheres 268
Aminated polysaccharide microspheres as DNA delivery systems 260
Encapsulation of dedifferentiated nasal septal chondrocytes in alginate based scaffolds for cartilage tissue engineering 258
Effect of dynamic three-dimensional culture on osteogenic potential of human periodontal ligament-derived mesenchymal stem cells entrapped in alginate microbeads 255
Analysis of the drug release profiles from formulations based on micro and nano systems 248
Accelerated functional maturation of isolated neonatal porcine cell clusters: In vitro and in vivo results in NOD mice 244
Cationic lipospheres as delivery systems for nucleic acid molecules 243
Acrylic microspheres for oral controlled release of the biguanide buformin 243
Suramin inhibits chikungunya virus replication through multiple mechanisms 243
Acute effects of lead on porcine neonatal Sertoli cells in vitro 240
In vitro stability of polymerase chain reaction-generated DNA fragments in serum and cell extracts 239
Delivery of suramin as an antiviral agent through liposomal systems 236
Acceleration of functional maturation and differentiation of neonatal porcine islet cell monolayers shortly in vitro cocultured with microencapsulated Sertoli cells 235
Design, preparation and characterization of alginate based microdevices for mesenchymal stem cell immunoisolation 232
Amphiphilic association systems for amphotericin B delivery 232
Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum 232
Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system 227
Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: Formulatory and drug release studies 226
Composite ECM-alginate microfibers produced by microfludics as scaffolds with biomineralisation potential 226
Human mesenchymal stem cells seeded on extracellular matrix scaffold: Viability and osteogenic potential 223
"Off-the-shelf" microfluidic devices for the production of liposomes for drug delivery 222
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 222
Data on scaling up and in vivo human study of progesterone lipid nanoparticles 222
Production of lipospheres as carriers for bioactive compounds 217
Antitumor activity of (trans)dermally delivered aromatic tetra-amidines 214
Antiproliferative effect and antiproteolytic activity of tetra-behzamidine derivatives 213
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 213
Liposomes as carriers for DNA-PNA hybrids 208
Microparticles as delivery systems for local delivery to the oral cavity. 206
Preparation of cell-encapsulation devices in confined microenvironment 206
Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior 206
Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles 205
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 205
Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion 204
CG Dinucleotides of class II MHC genes are mutation hot-spots 201
Gelified reverse micellar dispersions as percutaneous formulations 201
Encapsulation of cannabinoid drugs in nanostructured lipid carriers 201
Influence of formulation and process parameters on pellet production by powder layering technique 199
Automatic production of double coated alginate microcapsules: Analysis of the experimental parameters by design of experiments 199
A correlative imaging study of in vivo and ex vivo biodistribution of solid lipid nanoparticles 199
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 198
Comparative analysis of tetracycline-containing dental gels: poloxamer- and monoglyceride-based formulations 197
Binding of nuclear factors to the IFN-γ consensus sequence of the human HLA-DRα gene: effects of IFN-γ on tumor cell lines 197
Optimised production of multifunctional microfibres by microfluidic chip technology for tissue engineering applications 196
Cellulose acetate microparticles for Lab-on-a-chip applications 195
Microencapsulation procedures for the immunoisolation of Wharton’s Jelly mesenchymal stem cells: A review 195
Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate 193
Design, production and characterization of polymeric microparticles containing vitamins for in vitro cell treatment on lab-on-a-chip 192
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents 191
Bioglass-based composite microparticles: design, production and in vitro characterization 190
Long-term stability, functional competence, and safety of microencapsulated specific pathogen-free neonatal porcine Sertoli cells: A potential product for cell transplant therapy 188
Kinetics of bromocriptine release from microspheres: Comparative analysis between different in vitro models 186
Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia 185
Modulation of estrogen receptor gene transcription in breast cancer cells by liposome delivered decoy molecules 185
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA 184
Lipid nanoparticles for administration of poorly water soluble neuroactive drugs 183
Wharton's jelly-derived multifunctional hydrogels: New tools to promote intervertebral disc regeneration in vitro and ex vivo 182
Liposome-associated retinoids: production, characterization and antiproliferative activity on neoplastic cells 182
Effect of DNA complexation and freeze-drying on the physicochemical characteristics of cationic liposomes 182
Encapsulation of mesenchymal stem cells from Wharton's jelly in alginate microbeads 182
"In vitro" methylation of GCGC sites of the human HLA-DR alpha gene by E. coli HhaI methylase: effects of chromatin proteins. 181
Gelatin microspheres: Influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties 180
In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis 180
Application of a new, simple and economic colorimetric method for the determination of non-esterified fatty acids in vegetable oils 179
Encapsulation of mithramycin into polymeric micelles by microfluidics: Regulation of the expression of the human γ-globin genes 178
Properties and applications of liposomes in cosmetics 177
Comparative study on the release kinetics of methyl-nicotinate from topic formulations 177
In vitro effect on human leukemic K562 cells of co-administration of liposome-associated retinoids and cytosine arabinoside (Ara-C) 176
Decellularized Wharton's Jelly extracellular matrix (DWJM) as biological scaffold supporting cells from degenerated intervertebral disc. 175
Applications of Dielectrophoresis-based Lab-on-a-chip Devices in Pharmaceutical Sciences and Biomedicine. 175
Myrosinase-generated isothiocyanate from glucosinolates: Isolation, characterization and in vitro antiproliferative studies 174
Rheologic and NMR characterization of monoglyceride-based formulations 174
Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappa B transcription factors 174
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles 173
GELATIN MICROSPHERES AS A NEW APPROACH FOR THE CONTROLLED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES AND PCR-GENERATED DNA FRAGMENTS 173
Production of lipospheres for bioactive compounds delivery 171
Cubic Phases, Cubosomes and Ethosomes for Cutaneous Application 171
Testosterone and FSH modulate Sertoli cell extracellular secretion: Proteomic analysis 171
Prolongation of skin allograft survival in rats by the transplantation of microencapsulated xenogeneic neonatal porcine Sertoli cells 170
Correlation between skeletal progenitor cells' fate,transcriptional regulatory networks and three-dimension culture condition 170
Human leukemic K562 cells treated with cytosine arabinoside: enhancement of erythroid differentiation by retinoic acid and retinol 169
Sugar cross-linked gelatin for controlled release: microspheres and disks 169
Influence of liposomal formulation parameters on the in vitro absorption of methyl nicotinate 169
Liposome-based formulations for the antibiotic nonapeptide Leucinostatin A: Fourier transform infrared spectroscopy characterization and in vivo toxicologic study 169
Production and characterization of engineered alginate-based microparticles containing ECM powder for cell/tissue engineering applications 169
Production, physico-chemical characterization and biodistribution studies of lipid nanoparticles 169
Macrophages loaded with doxorubicin by ATP-mediated permeabilization: potential carriers for antitumor therapy 168
Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications 168
Cross-enzyme inhibition by gabexate mesylate: Formulation and reactivity study 167
Tripalmitin-based cationic lipospheres: preparation, characterization and in Lab-on-a-chip applications 167
Rheological and functional characterization of new antiinflammatory delivery systems designed for buccal administration 166
Preparation and characterization of Ca-alginate microspheres by a new emulsification method 166
Production of Eudragit microparticles by spray-drying technique: Influence of experimental parameters on morphological and dimensional characteristics 165
Design and production of alginate-based microdevices for Sertoli's cells encapsulation 164
Totale 20.388
Categoria #
all - tutte 187.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.003
Totale 199.581


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.047 0 0 165 125 116 87 123 128 79 219 288 717
2022/20232.271 294 103 38 272 339 383 93 211 283 13 138 104
2023/20241.156 139 161 63 30 93 280 37 58 10 21 27 237
2024/20254.619 138 77 371 112 610 359 143 360 831 544 641 433
2025/202613.389 1.102 788 1.284 1.863 1.702 815 1.393 849 1.293 1.517 502 281
2026/20271.957 410 870 677 0 0 0 0 0 0 0 0 0
Totale 40.734